2024-05-03 |
2024-05-03 |
VP
Vente planifiée
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
1 000
-1.4%
17,85
100 000
USD
|
1 000
-1.4%
|
17,85
|
100 000
USD
|
|
2024-05-03 |
2024-05-03 |
VP
Vente planifiée
|
York Charles N II
COO, CFO AND SECRETARY
Dirigeant
|
1 000
-3.6%
17,85
100 000
USD
|
1 000
-3.6%
|
17,85
|
100 000
USD
|
|
2024-05-03 |
2024-05-02 |
VP
Vente planifiée
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
1 000
-0.0%
17,94
100 000
USD
|
1 000
-0.0%
|
17,94
|
100 000
USD
|
|
2024-05-03 |
2024-05-02 |
VP
Vente planifiée
|
York Charles N II
COO, CFO AND SECRETARY
Dirigeant
|
1 000
-0.1%
17,90
100 000
USD
|
1 000
-0.1%
|
17,90
|
100 000
USD
|
|
2024-05-03 |
2024-05-01 |
VP
Vente planifiée
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
1 000
-9.7%
17,88
100 000
USD
|
1 000
-9.7%
|
17,88
|
100 000
USD
|
|
2024-05-03 |
2024-05-01 |
VP
Vente planifiée
|
York Charles N II
COO, CFO AND SECRETARY
Dirigeant
|
1 000
-18.8%
17,89
100 000
USD
|
1 000
-18.8%
|
17,89
|
100 000
USD
|
|
2024-04-22 |
2024-04-18 |
VP
Vente planifiée
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
1 000
-0.8%
16,02
100 000
USD
|
1 000
-0.8%
|
16,02
|
100 000
USD
|
|
2024-03-26 |
2024-03-25 |
VP
Vente planifiée
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
10 000
-0.8%
16,01
160 055
USD
|
10 000
-0.8%
|
16,01
|
160 055
USD
|
|
2024-03-13 |
2024-03-11 |
VP
Vente planifiée
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
30 000
-2.4%
15,24
457 314
USD
|
30 000
-2.4%
|
15,24
|
457 314
USD
|
|
2024-02-28 |
2024-02-27 |
VP
Vente planifiée
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
20 000
-1.6%
16,11
322 166
USD
|
20 000
-1.6%
|
16,11
|
322 166
USD
|
|
2024-02-20 |
2024-02-16 |
V
Vente
|
Blackman Samuel C.
HEAD OF RESEARCH AND DEVELOPME
Dirigeant
|
2 258
-0.2%
15,25
34 430
USD
|
2 258
-0.2%
|
15,25
|
34 430
USD
|
|
2024-02-20 |
2024-02-16 |
V
Vente
|
Dubow Adam
GENERAL COUNSEL
Dirigeant
|
3 242
-16.4%
15,25
49 434
USD
|
3 242
-16.4%
|
15,25
|
49 434
USD
|
|
2024-02-20 |
2024-02-16 |
V
Vente
|
York Charles N II
COO, CFO AND SECRETARY
Dirigeant
|
2 666
-1.0%
15,25
40 651
USD
|
2 666
-1.0%
|
15,25
|
40 651
USD
|
|
2024-02-20 |
2024-02-16 |
V
Vente
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
7 615
-1.0%
15,25
116 114
USD
|
7 615
-1.0%
|
15,25
|
116 114
USD
|
|
2023-11-17 |
2023-11-16 |
V
Vente
|
Dubow Adam
General Counsel
Dirigeant
|
5 313
-31.7%
11,69
62 109
USD
|
5 313
-31.7%
|
11,69
|
62 109
USD
|
|
2023-11-17 |
2023-11-16 |
V
Vente
|
Blackman Samuel C.
Head of Research and Developme
Dirigeant
|
709
-0.1%
11,69
8 288
USD
|
709
-0.1%
|
11,69
|
8 288
USD
|
|
2023-11-17 |
2023-11-16 |
V
Vente
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
3 107
-0.4%
11,69
36 321
USD
|
3 107
-0.4%
|
11,69
|
36 321
USD
|
|
2023-11-17 |
2023-11-16 |
V
Vente
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
956
-0.4%
11,69
11 176
USD
|
956
-0.4%
|
11,69
|
11 176
USD
|
|
2023-10-20 |
2023-10-20 |
A
Achat
|
AI Day1 LLC
Affiliate of 10% Owner
Actionnaire important
|
111 387
+0.9%
9,97
1 110 907
USD
|
111 387
+0.9%
|
9,97
|
1 110 907
USD
|
|
2023-10-20 |
2023-10-19 |
A
Achat
|
AI Day1 LLC
Affiliate of 10% Owner
Actionnaire important
|
384 400
+3.1%
10,06
3 867 372
USD
|
384 400
+3.1%
|
10,06
|
3 867 372
USD
|
|
2023-10-20 |
2023-10-18 |
A
Achat
|
AI Day1 LLC
Affiliate of 10% Owner
Actionnaire important
|
979 667
+8.6%
10,21
10 000 049
USD
|
979 667
+8.6%
|
10,21
|
10 000 049
USD
|
|
2023-08-17 |
2023-08-17 |
V
Vente
|
Blackman Samuel C.
Head of Research and Developme
Dirigeant
|
668
-0.1%
13,86
9 258
USD
|
668
-0.1%
|
13,86
|
9 258
USD
|
|
2023-08-17 |
2023-08-17 |
V
Vente
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
2 996
-0.4%
13,86
41 525
USD
|
2 996
-0.4%
|
13,86
|
41 525
USD
|
|
2023-08-17 |
2023-08-17 |
V
Vente
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
922
-0.3%
13,86
12 779
USD
|
922
-0.3%
|
13,86
|
12 779
USD
|
|
2023-06-12 |
2023-06-09 |
A
Achat
|
AI Day1 LLC
Affiliate of 10% Owner
Actionnaire important
|
769 230
+7.2%
13,00
9 999 990
USD
|
769 230
+7.2%
|
13,00
|
9 999 990
USD
|
|
2023-06-07 |
2023-06-05 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
1 229
-0.1%
16,00
19 664
USD
|
1 229
-0.1%
|
16,00
|
19 664
USD
|
|
2023-05-17 |
2023-05-16 |
V
Vente
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
3 104
-0.3%
13,12
40 732
USD
|
3 104
-0.3%
|
13,12
|
40 732
USD
|
|
2023-05-17 |
2023-05-16 |
V
Vente
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
692
-0.1%
13,12
9 081
USD
|
692
-0.1%
|
13,12
|
9 081
USD
|
|
2023-05-17 |
2023-05-16 |
V
Vente
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
955
-0.4%
13,12
12 532
USD
|
955
-0.4%
|
13,12
|
12 532
USD
|
|
2023-03-14 |
2023-03-10 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
10 000
-0.8%
18,05
180 484
USD
|
10 000
-0.8%
|
18,05
|
180 484
USD
|
|
2023-03-08 |
2023-03-07 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
12 500
-1.1%
20,01
250 114
USD
|
12 500
-1.1%
|
20,01
|
250 114
USD
|
|
2023-03-03 |
2023-03-01 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
25 000
-7.0%
18,61
465 303
USD
|
25 000
-7.0%
|
18,61
|
465 303
USD
|
|
2023-02-21 |
2023-02-17 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
9 377
-3.5%
20,03
187 790
USD
|
9 377
-3.5%
|
20,03
|
187 790
USD
|
|
2023-02-17 |
2023-02-16 |
V
Vente
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
3 022
-0.3%
19,57
59 150
USD
|
3 022
-0.3%
|
19,57
|
59 150
USD
|
|
2023-02-17 |
2023-02-16 |
V
Vente
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
930
-0.3%
19,57
18 203
USD
|
930
-0.3%
|
19,57
|
18 203
USD
|
|
2023-02-17 |
2023-02-16 |
V
Vente
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
674
-0.1%
19,57
13 192
USD
|
674
-0.1%
|
19,57
|
13 192
USD
|
|
2023-02-13 |
2023-02-10 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
10 000
-0.8%
20,07
200 659
USD
|
10 000
-0.8%
|
20,07
|
200 659
USD
|
|
2023-02-03 |
2023-02-01 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
1 106
-0.3%
21,69
23 988
USD
|
1 106
-0.3%
|
21,69
|
23 988
USD
|
|
2023-02-03 |
2023-02-01 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
23 894
-6.3%
21,21
506 806
USD
|
23 894
-6.3%
|
21,21
|
506 806
USD
|
|
2023-01-24 |
2023-01-23 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
12 500
-1.0%
22,00
274 988
USD
|
12 500
-1.0%
|
22,00
|
274 988
USD
|
|
2023-01-23 |
2023-01-20 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
10 000
-3.6%
22,75
227 523
USD
|
10 000
-3.6%
|
22,75
|
227 523
USD
|
|
2023-01-11 |
2023-01-10 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
2 500
-0.2%
23,20
58 011
USD
|
2 500
-0.2%
|
23,20
|
58 011
USD
|
|
2023-01-11 |
2023-01-10 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
7 500
-0.6%
22,75
170 633
USD
|
7 500
-0.6%
|
22,75
|
170 633
USD
|
|
2023-01-04 |
2023-01-03 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
7 610
-2.0%
21,31
162 174
USD
|
7 610
-2.0%
|
21,31
|
162 174
USD
|
|
2023-01-04 |
2023-01-03 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
17 390
-4.3%
20,36
353 973
USD
|
17 390
-4.3%
|
20,36
|
353 973
USD
|
|
2022-12-22 |
2022-12-21 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
12 500
-1.0%
20,32
253 969
USD
|
12 500
-1.0%
|
20,32
|
253 969
USD
|
|
2022-12-22 |
2022-12-20 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
10 000
-3.5%
20,07
200 650
USD
|
10 000
-3.5%
|
20,07
|
200 650
USD
|
|
2022-12-12 |
2022-12-08 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
4 358
-1.1%
22,08
96 210
USD
|
4 358
-1.1%
|
22,08
|
96 210
USD
|
|
2022-12-05 |
2022-12-02 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
5 000
-1.2%
21,55
107 726
USD
|
5 000
-1.2%
|
21,55
|
107 726
USD
|
|
2022-12-05 |
2022-12-01 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
900
-0.1%
22,16
19 940
USD
|
900
-0.1%
|
22,16
|
19 940
USD
|
|
2022-12-05 |
2022-12-01 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
9 100
-0.7%
21,38
194 590
USD
|
9 100
-0.7%
|
21,38
|
194 590
USD
|
|
2022-12-05 |
2022-12-01 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
240
-0.1%
22,34
5 361
USD
|
240
-0.1%
|
22,34
|
5 361
USD
|
|
2022-12-05 |
2022-12-01 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
4 760
-1.1%
21,72
103 393
USD
|
4 760
-1.1%
|
21,72
|
103 393
USD
|
|
2022-11-22 |
2022-11-21 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
300
-0.1%
21,39
6 417
USD
|
300
-0.1%
|
21,39
|
6 417
USD
|
|
2022-11-22 |
2022-11-21 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
9 700
-3.3%
20,74
201 153
USD
|
9 700
-3.3%
|
20,74
|
201 153
USD
|
|
2022-11-22 |
2022-11-21 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
400
-0.0%
21,38
8 552
USD
|
400
-0.0%
|
21,38
|
8 552
USD
|
|
2022-11-22 |
2022-11-21 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
12 100
-1.0%
20,74
250 927
USD
|
12 100
-1.0%
|
20,74
|
250 927
USD
|
|
2022-11-17 |
2022-11-16 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
430
-0.1%
21,46
9 228
USD
|
430
-0.1%
|
21,46
|
9 228
USD
|
|
2022-11-17 |
2022-11-16 |
V
Vente
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
377
-0.0%
21,46
8 090
USD
|
377
-0.0%
|
21,46
|
8 090
USD
|
|
2022-11-17 |
2022-11-16 |
V
Vente
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
1 513
-0.1%
21,46
32 469
USD
|
1 513
-0.1%
|
21,46
|
32 469
USD
|
|
2022-11-03 |
2022-11-02 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
5 000
-1.2%
20,01
100 069
USD
|
5 000
-1.2%
|
20,01
|
100 069
USD
|
|
2022-11-03 |
2022-11-01 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
10 000
-0.8%
20,01
200 050
USD
|
10 000
-0.8%
|
20,01
|
200 050
USD
|
|
2022-11-03 |
2022-11-01 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
5 000
-1.2%
20,04
100 209
USD
|
5 000
-1.2%
|
20,04
|
100 209
USD
|
|
2022-11-03 |
2022-11-01 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
10 000
-3.3%
20,03
200 313
USD
|
10 000
-3.3%
|
20,03
|
200 313
USD
|
|
2022-11-03 |
2022-11-01 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
12 500
-1.0%
20,03
250 355
USD
|
12 500
-1.0%
|
20,03
|
250 355
USD
|
|
2022-10-05 |
2022-10-04 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
5 000
-1.2%
20,00
100 000
USD
|
5 000
-1.2%
|
20,00
|
100 000
USD
|
|
2022-10-05 |
2022-10-03 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
10 000
-0.8%
19,99
199 852
USD
|
10 000
-0.8%
|
19,99
|
199 852
USD
|
|
2022-10-05 |
2022-10-03 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
10 000
-3.2%
20,05
200 473
USD
|
10 000
-3.2%
|
20,05
|
200 473
USD
|
|
2022-10-05 |
2022-10-03 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
12 500
-1.0%
20,05
250 646
USD
|
12 500
-1.0%
|
20,05
|
250 646
USD
|
|
2022-10-05 |
2022-10-03 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
5 000
-1.1%
20,06
100 315
USD
|
5 000
-1.1%
|
20,06
|
100 315
USD
|
|
2022-09-22 |
2022-09-21 |
V
Vente
|
Canaan XI L.P.
Actionnaire important
|
6 106
-0.1%
19,29
117 785
USD
|
6 106
-0.1%
|
19,29
|
117 785
USD
|
|
2022-09-22 |
2022-09-21 |
V
Vente
|
Canaan XI L.P.
Actionnaire important
|
607 497
-6.7%
18,54
11 262 994
USD
|
607 497
-6.7%
|
18,54
|
11 262 994
USD
|
|
2022-09-22 |
2022-09-21 |
V
Vente
|
Grant Julie Papanek
Administrateur non-exécutif
|
6 106
-0.1%
19,29
117 785
USD
|
6 106
-0.1%
|
19,29
|
117 785
USD
|
|
2022-09-22 |
2022-09-21 |
V
Vente
|
Grant Julie Papanek
Administrateur non-exécutif
|
607 497
-6.7%
18,54
11 262 994
USD
|
607 497
-6.7%
|
18,54
|
11 262 994
USD
|
|
2022-09-20 |
2022-09-20 |
V
Vente
|
Canaan XI L.P.
Actionnaire important
|
2 266
-0.0%
20,10
45 547
USD
|
2 266
-0.0%
|
20,10
|
45 547
USD
|
|